APA (7th ed.) Citation

PR, B., LI, R., NA, U., BS, D., YA, D., BK, H., . . . R, H. (2024). Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy. Hepatology communications, 8(8), . https://doi.org/10.1097/HC9.0000000000000502

Chicago Style (17th ed.) Citation

PR, Burchard, et al. "Pan-lysyl Oxidase Inhibition Disrupts Fibroinflammatory Tumor Stroma, Rendering Cholangiocarcinoma Susceptible to Chemotherapy." Hepatology Communications 8, no. 8 (2024). https://doi.org/10.1097/HC9.0000000000000502.

MLA (9th ed.) Citation

PR, Burchard, et al. "Pan-lysyl Oxidase Inhibition Disrupts Fibroinflammatory Tumor Stroma, Rendering Cholangiocarcinoma Susceptible to Chemotherapy." Hepatology Communications, vol. 8, no. 8, 2024, https://doi.org/10.1097/HC9.0000000000000502.